期刊文献+

D-二聚体、纤维蛋白原检测在宫颈癌患者中的临床意义 被引量:6

Clinical significance of detection of D-dimer and fibrinogen in patients with cervical cancer
下载PDF
导出
摘要 目的探讨宫颈癌患者D-二聚体(D-D)、纤维蛋白原(FIB)水平及其与临床病理特征的关系。方法回顾性分析98例初治宫颈癌患者(宫颈癌组)及52例宫颈良性病变患者(对照组)的临床病理资料。比较治疗前两组患者的基线D-D及FIB水平,分析宫颈癌患者D-D及FIB阳性率与临床病理特征的关系。结果宫颈癌组D-D、FIB阳性率均高于对照组(P<0.05);宫颈癌组高龄患者(年龄≥60岁)、功能状态评分≤70分者、存在淋巴结转移者的基线D-D、FIB阳性率均升高(均P<0.05),随着临床分期的增高,D-D、FIB阳性率亦呈增高趋势(P<0.05)。结论宫颈癌患者易处于高凝状态,且以高龄者、体能状况差者、临床分期晚期者、有淋巴结转移者明显。高凝状态宫颈癌患者可能预后不良。 Objective To explore the levels of D-dimer(D-D) and fibrinogen(FIB) ,and their relationship with clinicopathological features in patients with cervical cancer. Methods The clinicopathalogical data of 98 initially treated patients with cervical cancer( cervical cancer group) and 52 patients with cervical benign lesion( control group) were retrospectively analyzed. The baseline levels of D-D and FIB were compared between the two groups, and the relationship of positive rates of D-D and FIB with clinicopathological features in patients with cervical cancer was analyzed. Results The positive rates of D-D and FIB in the cervical cancer group were significantly higher than those in the control group ( P 〈 0.05 ). In the cervical cancer group, the positive rates of baseline D-D and FIB increased in the patients with advanced age( 960 years), Karnofsky score 470 and lymphatic metastasis (P 〈 0.05 ). The positive rates of D-D and FIB obtained increasing trend with the increase of clinical stage (P 〈 0.05 ). Conclusion The patients with cervical cancer easily suffer from hypercoagnlability, especially the patients with advanced age, poor physical condition, advanced clinical stage and lymphatic metastasis. Poor prognosis might be observed in cervical cancer patients with hypercoagnlability.
出处 《广西医学》 CAS 2016年第9期1242-1244,共3页 Guangxi Medical Journal
基金 新疆维吾尔自治区人民医院院内科研项目(20150117)
关键词 宫颈癌 D-二聚体 纤维蛋白原 高凝状态 Cervical cancer D-dimer Fibrinogen Hypercoagulability
  • 相关文献

参考文献13

二级参考文献41

  • 1冯海生,王金龙,钟亮星,陈琳娜.血浆D-二聚体和纤维蛋白原含量与恶性肿瘤相关性分析[J].实用医技杂志,2005,12(01B):158-160. 被引量:19
  • 2劳明,潘弘,张其进,黄文成,韦礼斌,朱波.血清CEA、Pro-GRP、CYFRA21-1及β_2-MG联合检测在肺癌诊断中的意义[J].实用医学杂志,2005,21(22):2574-2577. 被引量:9
  • 3林粤,韩玲霞.恶性肿瘤患者凝血指标测定的临床评价[J].现代中西医结合杂志,2006,15(5):636-637. 被引量:25
  • 4Dobromirski M,Cohen AT.How I manage venous thromboembolism risk in hospitalized medical patients[J].Blood,2012,120(8):1562-1569. 被引量:1
  • 5Khorana AA.Risk assessment for cancer-associated thrombosis:what is the best approach[J]- Thromb Res,2012,129(Suppl 1):S10-15. 被引量:1
  • 6Ahlbrecht J,Dickmann B,Ay C,et al.Tumor grade is associated with venous thromboembolism in patients with cancer:results from the Vienna Cancer and Thrombosis Study[J].J Clin Oncol,2012,30(31):3870-3875. 被引量:1
  • 7Dammacco F,Vacca A,Procaccio P,et al.Cancer-related coagulopathy(Trousseau's syndrome):review of the literature and experience of a single center of internal medicine[J].Clin Exp Med,2013,13(2):85-97. 被引量:1
  • 8Suzuki N,Yoshioka N,Ohara T,et al.Risk factors for perioperative venous thromboembolism:A retrospective study in Japanese women with gynecologic diseases[J].Thromb J,2010,8:17. 被引量:1
  • 9Lekovic D,Miljic P,Mihaljevic B.Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma[J].Thromb Res,2010,126(6):477-480. 被引量:1
  • 10Morii T,Mochizuki K,Tajima T,et al.Venous thromboembolism in the management of patients with musculoskeletal tumor[J].J Orthop Sci,2010,15(6):810-815. 被引量:1

共引文献57

同被引文献65

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部